Welcome to DZIF
It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues.
MERS-Coronavirus: Clinical tests of a vaccine are in preparation
DZIF scientists from the LMU München have successfully tested a candidate vaccine in animal models and are now preparing a clinical trial in humans.
In the DZIF, scientists prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus.
Fighting HIV with Antibodies
An international team of scientists, in collaboration with the DZIF, has now tested a new generation of antibodies in humans for the first time. They have demonstrated that these broadly neutralising antibodies significantly reduce the number of human immunodeficiency viruses (HIV) in infected patients’ blood.
24 June 2015 - PRESS RELEASE
Scientists have developed a new genetic method, with which they can not only predict which antibiotics result in resistance, but with which they can also say which compounds are effective against the respective tuberculosis (TB) pathogens. The results are published in the online edition of the international journal The Lancet Infectious Diseases. [ more ]
09 June 2015 - PRESS RELEASE
08 June 2015 - PRESS RELEASE
DZIF e.V. – Inhoffenstraße 7, 38124 Braunschweig, Germany
PHONE +49 531-6181 1152 EMAIL firstname.lastname@example.org